Trial updates and new biomarkers in the field of immunotherapy
Trial updates and new biomarkers in the field of
Trial updates and new biomarkers in the field of
Novel first-line options and other insights in E
Early-stage NSCLC: promising (neo)adjuvant appro
Preface – ASCO 2019 Elisabeth Quoix, MD Dep